Trevicta

Medicinal product

(Invented) name

Trevicta

Active substance (s)

Paliperidonas

Strength

175 mg

Pharmaceutical form

pailginto atpalaidavimo injekcinė suspensija

Route (s) of administration

leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N05AX13, Paliperidone

Marketing authorisation holder

Janssen-Cilag International N.V., Belgija

Date of authorisation

2014-12-05

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10c

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Prolonged release suspension for injection	1 vnt.
Paliperidonas	175 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
65964	80478	1080478	užpildytas švirkštas	N1 ir 2 adatos		Receptinis	EU/1/14/971/007	Tiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2014-12-05	Registruotas